Ratneswaran Culadeeban, Pengo Martino F, Xiao Sichang, Luo Yuanming, Rossi Gian Paolo, Polkey Michael I, Moxham John, Steier Joerg
a Faculty of Life Sciences and Medicine , King's College London , London , UK.
b Lane Fox Unit/Sleep Disorders Centre , Guy's & St Thomas' NHS Foundation Trust , London , UK.
Blood Press. 2018 Aug;27(4):206-214. doi: 10.1080/08037051.2018.1443391. Epub 2018 Feb 23.
Continuous positive airway pressure (CPAP) improves upper airway obstruction in patients with obstructive sleep apnoea (OSA), who often are overweight-obese. Although it is thought that CPAP improves long-term blood pressure control (BP), the impact of acute and short-term CPAP use on the cardiovascular system in obese patients has not been described in detail.
Obese patients (body mass index, BMI > 25 kg/m) with OSA were studied awake, supine during incremental CPAP titration (4-20 cmHO, +2 cmHO/3 mins). BP was measured continuously with a beat-to-beat BP monitor (Ohmeda 2300, Finapres Medical Systems, Amsterdam/NL), BP variability (BPV) was calculated as the standard deviation of BP at each CPAP level, the 95% confidence interval (95%CI) was calculated and changes in BP and BPV were reported.
15 patients (12 male, 48 ± 10) years, BMI 38.9 ± 5.8 kg/m) were studied; the baseline BP was 131.0 ± 10.2/85.1 ± 9.1 mmHg. BP and BPV increased linearly with CPAP titration (systolic BP r = 0.960, p < .001; diastolic BP r = 0.961, p < .001; systolic BPV r = 0.662, p = .026; diastolic BPV r = 0.886, p < .001). The systolic BP increased by +17% (+23.15 (7.9, 38.4) mmHg; p = .011) and the diastolic BP by +23% (+18.27 (2.33, 34.21) mmHg; p = .009), when titrating CPAP to 20 cmHO. Systolic BPV increased by +96% (+5.10 (0.67, 9.53) mmHg; p < .001) and was maximal at 14 cmHO, and diastolic BPV by +97% (+3.02 (0.26, 5.78) mmHg; p < .001) at 16 cmHO.
Short-term incremental CPAP leads to significant increases in BP and BPV in obese patients with OSA while awake. Careful titration of pressures is required to minimise the risk of nocturnal awakenings while improving BP control.
持续气道正压通气(CPAP)可改善阻塞性睡眠呼吸暂停(OSA)患者的上气道阻塞,这类患者通常超重或肥胖。尽管人们认为CPAP可改善长期血压控制(BP),但急性和短期使用CPAP对肥胖患者心血管系统的影响尚未得到详细描述。
对患有OSA的肥胖患者(体重指数,BMI>25kg/m²)进行研究,患者清醒、仰卧位,进行CPAP递增滴定(4 - 20cmH₂O,每3分钟增加2cmH₂O)。使用逐搏血压监测仪(Ohmeda 2300,菲纳普利医疗系统公司,阿姆斯特丹/荷兰)连续测量血压,计算每个CPAP水平下血压的标准差作为血压变异性(BPV),计算95%置信区间(95%CI),并报告血压和BPV的变化。
研究了15例患者(12例男性,年龄48±10岁,BMI 38.9±5.8kg/m²);基线血压为131.0±10.2/85.1±9.1mmHg。随着CPAP滴定,血压和BPV呈线性增加(收缩压r = 0.960,p<0.001;舒张压r = 0.961,p<0.001;收缩压BPV r = 0.662,p = 0.026;舒张压BPV r = 0.886,p<0.001)。当将CPAP滴定至20cmH₂O时,收缩压增加了17%(+23.15(7.9,38.4)mmHg;p = 0.011),舒张压增加了23%(+18.27(2.33,34.21)mmHg;p = 0.009)。收缩压BPV增加了96%(+5.10(0.67,9.53)mmHg;p<0.001),在14cmH₂O时达到最大值,舒张压BPV在16cmH₂O时增加了97%(+3.02(0.26,5.78)mmHg;p<0.001)。
短期递增CPAP会导致清醒的肥胖OSA患者血压和BPV显著升高。需要仔细滴定压力,以在改善血压控制时将夜间觉醒的风险降至最低。